Answers are grounded in this paper and cite their sources.
Sedative-hypnotics remain widely used in older adults despite safety concerns. We conducted a cross-sectional interviewer-administered survey of hospitalized patients ≥65 years with regular sedative-hypnotic use documented on admission to characterize use, knowledge of recommended duration and adverse effects, and clinician engagement in counseling and deprescribing. Among 88 participants (mean age 81.5; 60% women), only 18% reported any counseling on duration and/or adverse effects, and 1% were offered a nonpharmacological alternative. Deprescribing engagement was limited: 7% reported that a physician had offered stopping and 19% had tried to stop; fear of stopping was common (88%). Nevertheless, 35% said they would try to discontinue if their physician advised that they could stop, and 32% reported abnormal events since starting treatment. These exploratory findings suggest a potentially actionable care gap. Structured counseling, shared decision-making, deprescribing support, and access to behavioral insomnia therapies warrant prospective evaluation as strategies to improve sedative-hypnotic safety in older adults.
No takes yet. Share an insight, caveat, or question.
Lavon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: